News & Updates

Volatile organic compounds up hypertension risk
Volatile organic compounds up hypertension risk
27 Dec 2024

A recent study has found epidemiological evidence pointing to an association between environmental pollutants and hypertension. This finding calls attention to the contribution of nonoccupational volatile organic compounds (VOCs) to the risk of hypertension in the general population.

Volatile organic compounds up hypertension risk
27 Dec 2024
Novel vaccine passes phase II trial in virally suppressed CHB
Novel vaccine passes phase II trial in virally suppressed CHB
26 Dec 2024

Therapeutic vaccination with ChAdOx1-HBV/MVA-HBV (VTP-300) has generated CD4+ and CD8+ cells and reduced HBsAg in a subset of chronic hepatitis B (CHB) patients with baseline values <100 IU/ml, as shown in a phase Ib/IIa trial. Moreover, a significant decrease in surface antigen occurs when the vaccine is combined with low-dose nivolumab.

Novel vaccine passes phase II trial in virally suppressed CHB
26 Dec 2024